Kevin Conroy, EXACT Sciences CEO, discusses the latest breakthrough in screening for colon cancer.
(Reuters) - Exact Sciences Corp said its molecular screening test for colorectal cancer met the main goal of detecting the disease in more patients than other commonly used screening tests in a large late-stage study. Full story
Screenings and new surgical techniques are revolutionizing colon cancer treatment. KPRC's Rachel McNeill reports.
A controversial colon cancer awareness campaign, launched by the Minnesota Department of Health, is garnering strong reactions. KARE’s Dave Berggren reports.